Ez Massager 4

Description

Ez Massager 4 is a therapeutic device designed for muscle relaxation and pain relief. It features advanced technology to provide targeted massage therapy. The device is constructed with durable materials, ensuring longevity and consistent performance. Its ergonomic design allows for ease of use, accommodating various body contours. The Ez Massager 4 is suitable for both professional and personal use, making it a versatile addition to any wellness regimen.

Uses and Indications

This drug is indicated for the instant relief of pain associated with various musculoskeletal conditions, including arthritis, backache, bruises, cramps, sprains, and strains.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

Healthcare professionals are advised to massage the medication into the painful area until it is thoroughly absorbed into the skin. This application may be repeated as necessary, but should not exceed 3 to 4 times per day. Care should be taken to ensure that the area is clean and dry prior to application to optimize absorption and effectiveness.

Contraindications

There are no specific contraindications listed for this product. However, it is essential to keep the product out of reach of children. In the event of accidental ingestion, immediate medical assistance should be sought or contact with a Poison Control Center is advised.

Warnings and Precautions

For external use only. This product should not be applied to wounds or damaged skin in conjunction with a heating pad, as this may exacerbate the condition.

Healthcare professionals are advised to instruct patients to seek medical advice prior to use if any of the following conditions are present: redness over the affected area, worsening of conditions or persistence of symptoms beyond 7 days, recurrence of symptoms after initial resolution within a few days, or excessive skin irritation. Additionally, pregnant or breastfeeding individuals should consult a healthcare provider before using this product.

It is imperative to keep this product out of reach of children. In the event of accidental ingestion, immediate medical assistance should be sought, or contact with a Poison Control Center is recommended.

No specific general precautions or laboratory tests have been identified for this product.

Side Effects

Patients should be aware of the following warnings and precautions associated with the use of this product. It is intended for external use only and should not be applied to wounds or damaged skin, particularly when using a heating pad.

Patients are advised to consult a healthcare professional before using this product if they experience redness over the affected area, if their condition worsens or symptoms persist for more than 7 days, if symptoms resolve and then recur within a few days, or if excessive skin irritation occurs. Additionally, individuals who are pregnant or breastfeeding should seek medical advice prior to use.

These precautions are essential to ensure the safe and effective use of the product, minimizing the risk of adverse reactions.

Drug Interactions

There are currently no specific drug interactions identified for the medication. Additionally, no interactions with laboratory tests have been reported. Therefore, no dosage adjustments or monitoring recommendations are necessary at this time. It is advisable for healthcare professionals to remain vigilant and consult updated resources as new data may emerge.

Packaging & NDC

Below are the non-prescription pack sizes of Ez Massager 4 (menthol). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients should be advised to keep this medication out of reach of children. In the event of accidental ingestion, immediate medical assistance should be sought, or the Poison Control Center should be contacted without delay.

Geriatric Use

There is no specific information regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as they may have altered pharmacokinetics and pharmacodynamics. Close monitoring is recommended to ensure safety and efficacy in this population.

Pregnancy

Pregnant patients and those who are breastfeeding should consult a healthcare professional before using this medication. The safety of this drug during pregnancy has not been established, and potential risks to fetal outcomes are not fully known. Therefore, it is essential for women of childbearing potential to discuss their individual circumstances with their healthcare provider to weigh the benefits and risks associated with the use of this medication during pregnancy and lactation.

Lactation

Lactating mothers should be aware that the use of this medication during breastfeeding has not been fully evaluated. There is limited information regarding the excretion of this drug in human breast milk. Therefore, caution is advised when administering this medication to nursing mothers.

Breastfed infants may be at risk if the mother takes this medication, and the potential effects on the nursing infant are not well characterized. Healthcare professionals should weigh the benefits of treatment against the potential risks to the infant when considering the use of this medication in lactating mothers.

Renal Impairment

There is no specific information regarding renal impairment, dosage adjustments, special monitoring, or safety considerations for patients with reduced kidney function. Healthcare professionals should exercise caution and consider individual patient factors when treating patients with renal impairment, as the absence of detailed guidance necessitates careful clinical judgment.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the absence of specific information regarding overdosage, healthcare professionals are advised to exercise caution and adhere to general principles of management in cases of suspected overdose.

It is essential to monitor the patient closely for any potential symptoms that may arise, as the clinical presentation can vary depending on the substance involved and the individual patient's response. Common symptoms of overdose may include, but are not limited to, altered mental status, cardiovascular instability, respiratory distress, and gastrointestinal disturbances.

In the event of an overdose, immediate medical attention should be sought. Healthcare providers should initiate supportive care, which may include maintaining airway patency, providing supplemental oxygen, and ensuring adequate circulation. The use of activated charcoal may be considered if the patient presents within a suitable timeframe and if the ingestion was recent.

Furthermore, specific antidotes or treatments may be indicated based on the substance involved in the overdose. It is crucial for healthcare professionals to consult relevant clinical guidelines and toxicology resources to determine the most appropriate management strategies.

In summary, while no specific overdosage information is available, vigilance and prompt intervention are paramount in managing potential overdose situations.

Nonclinical Toxicology

There is currently no available information regarding teratogenic effects, non-teratogenic effects, or any specific findings in nonclinical toxicology studies. Additionally, no data has been provided concerning animal pharmacology and toxicology.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to keep this medication out of the reach of children. It is crucial to emphasize that if the medication is swallowed, patients must seek medical help or contact a Poison Control Center immediately. This information is vital for ensuring the safety of children and preventing potential harm.

Storage and Handling

The product is supplied in a configuration that ensures optimal handling and storage. It should be stored at room temperature, away from direct sunlight and moisture. To maintain safety, it is essential to keep the product out of reach of children.

Care should be taken to avoid contact with eyes or mucous membranes during handling. Additionally, it is advised not to bandage tightly when applying the product to ensure proper circulation and comfort.

Additional Clinical Information

The product is administered topically, with patients advised to massage it into the painful area until fully absorbed into the skin. This application may be repeated as necessary, but should not exceed 3 to 4 times per day.

Clinicians should counsel patients to avoid contact with eyes or mucous membranes and to refrain from tightly bandaging the area. It is crucial to keep the product out of reach of children; if ingested, medical assistance or contact with a Poison Control Center should be sought immediately.

Drug Information (PDF)

This file contains official product information for Ez Massager 4, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)